Karvezide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Karvezide, covering 2025-09-25 to 2025-09-25. Get the full timeline:
Most recent: EMA Authorised: Karvezide (irbesartan;hydrochlorothiazide) — Sanofi Winthrop Industrie